| Company Name: |
Lynnchem |
| Tel: |
86-(0)29-85992781 17792393971 |
| Email: |
info@lynnchem.com |
| Company Name: |
Novachemistry |
| Tel: |
44-20819178-90 02081917890 |
| Email: |
info@novachemistry.com |
|
| | OrfaMide A Basic information |
| Product Name: | OrfaMide A | | Synonyms: | OrfaMide A;L-Valine, N-(3-hydroxy-1-oxotetradecyl)-L-leucyl-D-α-glutamyl-D-allothreonyl-D-alloisoleucyl-L-leucyl-D-seryl-L-leucyl-L-leucyl-D-seryl-, (10→3)-lactone | | CAS: | 939960-34-6 | | MF: | C64H114N10O17 | | MW: | 1295.67 | | EINECS: | | | Product Categories: | | | Mol File: | 939960-34-6.mol |  |
| | OrfaMide A Chemical Properties |
| Boiling point | 1503.0±65.0 °C(Predicted) | | density | 1.19±0.1 g/cm3(Predicted) | | solubility | DMF: soluble; DMSO: soluble; Ethanol: soluble; Methanol: soluble | | form | A solid | | pka | 4.43±0.10(Predicted) | | Sequence | {3-hydroxy-1-oxotetradecyl}-Leu-Glu-Thr-Ile-Leu-Ser-Leu-Leu-Ser-Val (Lactam bridge: Thr3-Val10) |
| | OrfaMide A Usage And Synthesis |
| Uses | Orfamide A is the major component of a family of cyclic lipopeptides produced by Pseudomonas fluorescens, reported in 2007. The orfamides were discovered by employing genomic analysis with an isotope-guided fractionation to identify metabolites produced by orphan gene clusters containing non-ribosomal peptide synthetases. Orfamide A has received scant investigation of its bioprofile but appears to be a selective antifungal agent. Uniquely, orfamide A lyses zoospores of the oomycete, Phytophthora ramorum, the cause of sudden oak death. Orfamide A has a profound effect on the swarming motility of bacteria on agar surfaces. | | Uses | Orfamide A is a possible antifungal agent. Orfamide A is the major component of a family of cyclic lipopeptides produced by Pseudomonas fluorescens, reported in 2007. |
| | OrfaMide A Preparation Products And Raw materials |
|